Hawkins Richard J
SEC insider (Form 3/4/5 filer). CIK 0001307632. Director at CERENOME, INC. (CNSY) and 2 other issuers. 16 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in HOUSTON, TX.
Companies Hawkins Richard J has filed insider reports for
- CERENOME, INC. (CNSY): Director
- Savara Inc (SVRA): Director
- LUMOS PHARMA, INC. ((LUMO)): Director, Officer, Chief Executive Officer
Hawkins Richard J
CIK: 0001307632
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
/logo?size=32)
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Oct 1, 2026CNSY
CERENOME, INC.
ExerciseDirect921 shares- - Jul 1, 2026PSTV
PLUS THERAPEUTICS, INC.
ExerciseDirect922 shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
3.7K shares- - May 14, 2026PSTV
PLUS THERAPEUTICS, INC.
AwardDirectRestricted Stock Units
3.7K shares- - Dec 9, 2025SVRA
Savara Inc
AwardDirect40K shares- - Nov 14, 2025SVRA
Savara Inc
ExerciseDirect5.9K shares at avg. $1.46$9K - Aug 13, 2025PSTV
PLUS THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
397.8K shares- - Jun 20, 2025SVRA
Savara Inc
PurchaseDirect48.2K shares at avg. $2.04$99K - Feb 18, 2025PSTV
PLUS THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
40.1K shares- - Dec 16, 2024SVRA
Savara Inc
SaleDirect8K shares at avg. $3.32$27K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  CNSY CERENOME, INC. | Exercise | 921 | - | $0 | Direct |
| Jul 1, 2026 |  PSTV PLUS THERAPEUTICS, INC. | Exercise | 922 | - | $0 | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 3,686 | - | - | Direct |
| May 14, 2026 | PSTV PLUS THERAPEUTICS, INC. | Award Restricted Stock Units | 3,686 | - | - | Direct |
| Dec 9, 2025 |  SVRA Savara Inc | Award | 40,000 | - | - | Direct |
| Nov 14, 2025 | SVRA Savara Inc | Exercise | 5,860 | $1.46 | $8,556 | Direct |
| Aug 13, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 397,794 | - | - | Direct |
| Jun 20, 2025 | SVRA Savara Inc | Purchase | 48,225 | $2.04 | $98,572 | Direct |
| Feb 18, 2025 | PSTV PLUS THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 40,122 | - | - | Direct |
| Dec 16, 2024 | SVRA Savara Inc | Sale | 8,000 | $3.32 | $26,569 | Direct |
1-10 of 16 transactions